The relationship between CRP gene polymorphism (rs2794521, rs3091244), ASDAS-CRP and ASDAS-ESR in ankylosing spondylitis

References

• Zochling J, Brandt J, Braun J. The current concept of spondyloarthritis with special emphasis on undifferentiated spondyloarthritis. Rheumatology. 2005;44(12):1483–91.
   PubMed Web of Science ®Google Scholar
• Kelley J, Walter L, Trowsdale J. Comparative genomics of major histocompatibility complexes. Immunogenetics. 2005;56(10):683–95.
   PubMed Web of Science ®Google Scholar
• McHugh K, Bowness P. The link between HLA-B27 and SpA – new ideas on an old problem. Rheumatology. 2012;51(9):1529–39.
   PubMed Web of Science ®Google Scholar
• Garchon HJ, Chiocchia G, Breban M. Brief report: the IL23R nonsynonymous polymorphism rs11209026 is associated with radiographic sacroiliitis in spondyloarthritis. Arthritis Rheum. 2013;65:2655–60.
   PubMedGoogle Scholar
• Wei JC-C, Hung K-S, Hsu Y-W, Wong R-H, Huang C-H, Jan M-S, et al. Genetic polymorphisms of stromal interaction molecule 1 associated with the erythrocyte sedimentation rate and C-reactive protein in HLA-B27 positive ankylosing spondylitis patients. PLoS One. 2012;7(12):e49698.
   PubMed Web of Science ®Google Scholar
• Liao Z, Lin Z, Xu M, Hu Z, Li T, Wei Q, et al. Clinical features of axial undifferentiated spondyloarthritis (USpA) in China: HLA-B27 is more useful for classification than MRI of the sacroiliac joint. Scand J Rheumatol. 2011;40(6):439–43.
   PubMed Web of Science ®Google Scholar
• Carter KW, Pluzhnikov A, Timms AE, Miceli-Richard C, Bourgain C, Wordsworth BP, et al. Combined analysis of three whole genome linkage scans for ankylosing spondylitis. Rheumatology. 2007;46(5):763–71.
   PubMed Web of Science ®Google Scholar
• Wang C-M, Ho H-H, Chang S-W, Wu Y-J, Lin J-C, Chang P-Y, et al. ERAP1 genetic variations associated with HLA-B27 interaction and disease severity of syndesmophytes formation in Taiwanese ankylosing spondylitis. Arthritis Res Ther. 2012;14(3):R125.
   PubMed Web of Science ®Google Scholar
• Zhang Z, Dai D, Yu K, Yuan F, Jin J, Ding L, et al. Association of HLA‐B27 and ERAP1 with ankylosing spondylitis susceptibility in Beijing Han Chinese. Tissue Antigens. 2014;83(5):324–9.
   PubMedGoogle Scholar
• Davidson SI, Liu Y, Danoy PA, Wu X, Thomas GP, Jiang L, et al. Association of STAT3 and TNFRSF1A with ankylosing spondylitis in Han Chinese. Ann Rheum Dis. 2011;70(2):289–92.
   PubMed Web of Science ®Google Scholar
• Akbulut E, Erdemir A, Özgen M, Baskin Y, Güleç F, Turgut Balik D. Genotyping and analysis of rs27037 polymorphism for ankylosing spondylitis. Sigma J Eng Nat Sci. 2015;6(1):117–25.
   Google Scholar
• Lunetta KL. Genetic association studies. Circulation. 2008;118(1):96–101.
   PubMed Web of Science ®Google Scholar
• Kushner I. C-reactive protein in rheumatology. Arthritis Rheum. 1991;35:982–4.
   Google Scholar
• Goldman ND, Liu T, Lei K-J. Structural analysis of the locus containing the human C-reactive protein gene and its related pseudogene. J Biol Chem. 1987;262:7001–5.
   PubMed Web of Science ®Google Scholar
• Dougados M, Gueguen A, Nakache JP, Velicitat P, Zeidler H, Veys E, et al. Clinical relevance of C-reactive protein in axial involvement of ankylosing spondylitis. J Rheumatol. 1999;26:971–4.
   PubMed Web of Science ®Google Scholar
• Consortium GP. A map of human genome variation from population-scale sequencing. Nature. 2010;467:1061–73.
   PubMed Web of Science ®Google Scholar
• Taira C, Matsuda K, Yamaguchi A, Sueki A, Koeda H, Takagi F, et al. Novel high-speed droplet-allele specific-polymerase chain reaction: application in the rapid genotyping of single nucleotide polymorphisms. Clin Chim Acta. 2013;424:39–46.
   PubMed Web of Science ®Google Scholar
• Grin B, Loeb S, Roehl K, Cooper PR, Catalona WJ, Helfand BT, et al. A rare 8q24 single nucleotide polymorphism (SNP) predisposes North American men to prostate cancer and possibly more aggressive disease. BJU Int. 2015;115(1):101–5.
   PubMed Web of Science ®Google Scholar
• He Q, He Q, Liu X, Wei Y, Shen S, Hu X, et al. Genome-wide prediction of cancer driver genes based on SNP and cancer SNV data. Am J Cancer Res. 2014;4:394.
   PubMed Web of Science ®Google Scholar
• Lukas C, Landewe R, Sieper J, Dougados M, Davis J, Braun J, for the Assessment of SpondyloArthritis international Society, et al. Development of an ASAS-endorsed disease activity score (ASDAS) in patients with ankylosing spondylitis. Ann Rheum Dis. 2008;68(1):18–24.
   PubMed Web of Science ®Google Scholar
• van der Heijde D, Lie E, Kvien TK, Sieper J, Van den Bosch F, Listing J, for the Assessment of SpondyloArthritis international Society (ASAS), et al. ASDAS, a highly discriminatory ASAS-endorsed disease activity score in patients with ankylosing spondylitis. Ann Rheum Dis. 2009;68(12):1811–8.
   PubMed Web of Science ®Google Scholar
• Spoorenberg A, van der Heijde D, de Klerk E, Dougados M, de Vlam K, Mielants H, et al. Relative value of erythrocyte sedimentation rate and C-reactive protein in assessment of disease activity in ankylosing spondylitis. J Rheumatol. 1999;26:980–4.
   PubMed Web of Science ®Google Scholar
• Akbal A, Reşorlu H, Gökmen F, Savaş Y, Zateri Ç, Sargin B, et al. The relationship between C-reactive protein rs3091244 polymorphism and ankylosing spondylitis. Int J Rheum Dis. 2016;19(1):43–8.
   PubMed Web of Science ®Google Scholar
• Claushuis TA, de Vries MK, van der Weijden MA, Visman IM, Nurmohamed MT, Twisk JW, et al. C-reactive protein polymorphisms influence serum CRP-levels independent of disease activity in ankylosing spondylitis. Clin Exp Rheumatol. 2015;33(2):159–65.
   PubMed Web of Science ®Google Scholar
• Rhodes B, Merriman ME, Harrison A, Nissen MJ, Smith M, Stamp L, et al. A genetic association study of serum acute-phase C-reactive protein levels in rheumatoid arthritis: implications for clinical interpretation. PLoS Med. 2010;7(9):e1000341.
   PubMed Web of Science ®Google Scholar
• Fernández-Espertero C, de Miguel E, Loza E, Tomero E, Gobbo M, Descalzo M, et al. Validity of the Ankylosing Spondylitis Disease Activity Score (ASDAS) in patients with early spondyloarthritis from the Esperanza programme. Ann Rheum Dis. 2014;73:1350–5.
   PubMedGoogle Scholar
• Plant D, Ibrahim I, Lunt M, Eyre S, Flynn E, Hyrich KL, et al. Correlation of C-reactive protein haplotypes with serum C-reactive protein level and response to anti-tumor necrosis factor therapy in UK rheumatoid arthritis patients: results from the Biologics in Rheumatoid Arthritis Genetics and Genomics Study Syndicate cohort. Arthritis Res Ther. 2012;14:R214.
   PubMedGoogle Scholar
• Ammitzbøll CG, Steffensen R, Bøgsted M, Hørslev-Petersen K, Hetland ML, Junker P, et al. CRP genotype and haplotype associations with serum C-reactive protein level and DAS28 in untreated early rheumatoid arthritis patients. Arthritis Res Ther. 2014;16(5):475.
   PubMed Web of Science ®Google Scholar
• Berger P, McConnell JP, Nunn M, Kornman KS, Sorrell J, Stephenson K, et al. C-reactive protein levels are influenced by common IL-1 gene variations. Cytokine. 2002;17(4):171.
   PubMed Web of Science ®Google Scholar
• Eklund C, Jahan F, Pessi T, Lehtimäki T, Hurme M. IL1B gene polymorphism is associated with baseline C-reactive protein levels in healthy individuals. Eur Cytokine Netw. 2003;14:168–171.
   PubMed Web of Science ®Google Scholar
• Suzuki G, Izumi S, Hakoda M, Takahashi N. LTA 252G allele containing haplotype block is associated with high serum C-reactive protein levels. Atherosclerosis. 2004;176(1):91–4.
   PubMed Web of Science ®Google Scholar
• Miller DT, Zee RYL, Suk Danik J, Kozlowski P, Chasman DI, Lazarus R, et al. Association of common CRP gene variants with CRP levels and cardiovascular events. Ann Hum Genet. 2005;69(Pt 6):623–38.
   PubMedGoogle Scholar
• Carlson CS, Aldred SF, Lee PK, Tracy RP, Schwartz SM, Rieder M, et al. Polymorphisms within the C-reactive protein (CRP) promoter region are associated with plasma CRP levels. Am J Hum Genet. 2005;77(1):64–77.
   PubMed Web of Science ®Google Scholar
• Szalai AJ, Wu J, Lange EM, McCrory MA, Langefeld CD, Williams A, et al. Single-nucleotide polymorphisms in the C-reactive protein (CRP) gene promoter that affect transcription factor binding, alter transcriptional activity, and associate with differences in baseline serum CRP level. J Mol Med. 2005;83(6):440–7.
   PubMed Web of Science ®Google Scholar
• Balistreri CR, Vasto S, Listi F, Grimaldi MP, Lio D, Colonna-Romano G, et al. Association between +1059G/C CRP polymorphism and acute myocardial infarction in a cohort of patients from Sicily: a pilot study. Ann N Y Acad Sci. 2006;1067:276–281.
   Google Scholar
• Brull DJ, Serrano N, Zito F, Jones L, Montgomery HE, Rumley A, et al. Human CRP gene polymorphism influences CRP levels. Arterioscler Thromb Vasc Biol. 2003;23:2063–9.
   PubMed Web of Science ®Google Scholar
• Zee RY, Ridker PM. (Polymorphism in the human C-reactive protein (CRP) gene, plasma concentrations of CRP, and the risk of future arterial thrombosis. Atherosclerosis. 2002;162(1):217–9.
   PubMed Web of Science ®Google Scholar
• Suk Danik J, Chasman DI, Cannon CP, Miller DT, Zee RYL, Kozlowski P, et al. Influence of genetic variation in the C-reactive protein gene on the inflammatory response during and after acute coronary ischemia. Ann Hum Genet. 2006;70(Pt 6):705–16.
   PubMedGoogle Scholar